Detalles de la búsqueda
1.
Minimally Invasive Breast Biopsy After Neoadjuvant Systemic Treatment to Identify Breast Cancer Patients with Residual Disease for Extended Neoadjuvant Treatment: A New Concept.
Ann Surg Oncol
; 31(2): 957-965, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37947974
2.
Diagnosing Pathologic Complete Response in the Breast After Neoadjuvant Systemic Treatment of Breast Cancer Patients by Minimal Invasive Biopsy: Oral Presentation at the San Antonio Breast Cancer Symposium on Friday, December 13, 2019, Program Number GS5-03.
Ann Surg
; 275(3): 576-581, 2022 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32657944
3.
ASO Visual Abstract: Minimally-Invasive Breast Biopsy After Neoadjuvant Systemic Treatment to Identify Breast Cancer Patients with Residual Disease for Extended Neoadjuvant Treatment-A New Concept.
Ann Surg Oncol
; 31(2): 1033-1034, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38093166
4.
CD24 Ala57Val polymorphism predicts pathologic complete response to sequential anthracycline- and taxane-based neoadjuvant chemotherapy for primary breast cancer.
Breast Cancer Res Treat
; 132(3): 819-31, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21960110
5.
Intelligent Vacuum-Assisted Biopsy to Identify Breast Cancer Patients With Pathologic Complete Response (ypT0 and ypN0) After Neoadjuvant Systemic Treatment for Omission of Breast and Axillary Surgery.
J Clin Oncol
; 40(17): 1903-1915, 2022 06 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35108029
6.
PPFIA1 and CCND1 are frequently coamplified in breast cancer.
Genes Chromosomes Cancer
; 49(1): 1-8, 2010 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-19787783
7.
Altona Prognostic Index: A New Prognostic Index for ER-Positive and Her2-Negative Breast Cancer of No Special Type.
Cancers (Basel)
; 13(15)2021 Jul 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-34359699
8.
Desmoid Type Fibromatosis of the Breast: Ten-Year Institutional Results of Imaging, Histopathology, and Surgery.
Breast Care (Basel)
; 16(1): 77-84, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33708054
9.
NY-CO-58/KIF2C is overexpressed in a variety of solid tumors and induces frequent T cell responses in patients with colorectal cancer.
Int J Cancer
; 127(2): 381-93, 2010 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-19937794
10.
Is Breast Surgery Necessary for Breast Carcinoma in Complete Remission Following Neoadjuvant Chemotherapy?
Geburtshilfe Frauenheilkd
; 78(1): 48-53, 2018 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-29375145
11.
Improved Risk Stratification for Breast Cancer Samples Based on the Expression Ratio of the Estrogen and Progesterone Receptor.
Anticancer Res
; 36(8): 3855-63, 2016 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-27466487
12.
Topoisomerase-II alpha expression as a predictive marker in a population of advanced breast cancer patients randomly treated either with single-agent doxorubicin or single-agent docetaxel.
Mol Cancer Ther
; 3(10): 1207-14, 2004 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-15486187
13.
Successful reduction of alopecia induced by anthracycline and taxane containing adjuvant chemotherapy in breast cancer - clinical evaluation of sensor-controlled scalp cooling.
Springerplus
; 3: 500, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25279292
14.
MarginProbe®--final results of the German post-market study in breast conserving surgery of ductal carcinoma in situ.
Breast
; 23(1): 94-6, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24291375
15.
Tubular breast cancer. A retrospective study.
Anticancer Res
; 34(7): 3647-56, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24982382
16.
Mastectomy trends for early-stage breast cancer: a report from the EUSOMA multi-institutional European database.
Eur J Cancer
; 48(13): 1947-56, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22483323
Resultados
1 -
16
de 16
1
Próxima >
>>